apomorphine has been researched along with sodium metabisulfite in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Astorga, S; Espinosa, R; Fernández, S; Foncubierta, A; Gutiérrez, D; Leon, A | 1 |
Digenis, GA; Sreeramoju, MK | 1 |
Borgemeester, RWK; Schuttelaar, MLA; van Laar, T | 1 |
3 other study(ies) available for apomorphine and sodium metabisulfite
Article | Year |
---|---|
Immediate type 1 hypersensitivity to apomorphine: a case report.
Topics: Antiparkinson Agents; Apomorphine; Double-Blind Method; Drug Eruptions; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Injections, Subcutaneous; Intradermal Tests; Male; Middle Aged; Patch Tests; Single-Blind Method; Skin Tests; Sulfites | 2011 |
Nucleophilic Addition in Aqueous Apomorphine Formulation Solutions in the Presence of Sodium Metabisulfite: Implications for Formulation Development and Manufacturing.
Topics: Antioxidants; Apomorphine; Benzoquinones; Dopamine Agonists; Drug Compounding; Excipients; Oxidation-Reduction; Spectrometry, Mass, Electrospray Ionization; Sulfites; Water | 2018 |
Cutaneous adverse drug reaction after apomorphine infusion, possibly caused by a systemic type IV hypersensitivity reaction to sodium metabisulfite: Report of 2 cases.
Topics: Adult; Aged; Apomorphine; Dopamine Agonists; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Hypersensitivity, Delayed; Infusions, Subcutaneous; Male; Parkinson Disease; Patch Tests; Preservatives, Pharmaceutical; Sulfites | 2018 |